REDUCE Trial- Reducing Prolapse Recurrence — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

REDUCE Trial- Reducing Prolapse Recurrence — Stella

Home/Prolapse; Female/

View on ClinicalTrials.gov

Recruiting

Back to Prolapse; Female trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Northwestern University, Chicago, Illinois

Key details

Sponsor

Northwestern University

Collaborators

The Institute of Pelvic Medicine & Reconstructive Surgery, Allentown, Pennsylvania, University of Kansas

Enrollment target

~200 participants

Started

November 2021

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Sex

Female only

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.